CENTER VALLEY, Pa., Feb. 21, 2018 /PRNewswire/ -- Aesculap, Inc. is pleased to announce the asset acquisition of Dextera Surgical Inc. Aesculap is an industry expert in providing comprehensive solutions and differentiated technologies to help meet the needs of the changing healthcare environment.
Dextera designs, manufactures and markets proprietary medical devices for surgical procedures, including surgical staplers and innovative devices for coronary artery bypass graft (CABG) surgery. Aesculap will oversee operations in Redwood City, CA to continue the manufacturing and distribution of Dextera's products.
Through the acquisition, Aesculap expands its portfolio of premium solutions for beating heart coronary and video-assisted thoracic surgery. The innovative MicroCutter 5/80 stapler, PAS-Port® proximal anastomosis system, C-Port® distal anastomosis system and technology portfolio supports Aesculap's growth in the cardio-thoracic surgery market.
About Aesculap, Inc. Aesculap, Inc., a B. Braun company, is part of a 180-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for general surgery, neurosurgery and closure technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients' lives. For more information, call 800-282-9000 or visit aesculapusa.com.